{"mpox_priority_code":"01","mpox_priority":"Pathogen: natural history, transmission and diagnostics","mpox_subpriority_code":"0101","mpox_subpriority":"Development of equitable, accessible, safe & effective diagnostics (including POC)"}
{"mpox_priority_code":"01","mpox_priority":"Pathogen: natural history, transmission and diagnostics","mpox_subpriority_code":"0102","mpox_subpriority":"Research for enhanced understanding of the disease"}
{"mpox_priority_code":"01","mpox_priority":"Pathogen: natural history, transmission and diagnostics","mpox_subpriority_code":"0103","mpox_subpriority":"Viral evolution in different contexts & implications"}
{"mpox_priority_code":"02","mpox_priority":"Animal and environmental research and research on diseases vectors","mpox_subpriority_code":"0201","mpox_subpriority":"Investigation of zoonotic transmission & reservoirs"}
{"mpox_priority_code":"03","mpox_priority":"Epidemiological studies","mpox_subpriority_code":"0301","mpox_subpriority":"Epidemiology & transmission dynamics of mpox including sexual transmission."}
{"mpox_priority_code":"03","mpox_priority":"Epidemiological studies","mpox_subpriority_code":"0302","mpox_subpriority":"Disease epidemiology & risk factors  & modes of transmission"}
{"mpox_priority_code":"03","mpox_priority":"Epidemiological studies","mpox_subpriority_code":"0303","mpox_subpriority":"Transmission dynamics including via various modes"}
{"mpox_priority_code":"03","mpox_priority":"Epidemiological studies","mpox_subpriority_code":"0304","mpox_subpriority":"Transmission dynamics including risk & determinants of acquisition"}
{"mpox_priority_code":"03","mpox_priority":"Epidemiological studies","mpox_subpriority_code":"0305","mpox_subpriority":"Ongoing assessment & evaluation of surveillance"}
{"mpox_priority_code":"04","mpox_priority":"Clinical characterisation and management","mpox_subpriority_code":"0401","mpox_subpriority":"Promote improved understanding of the disease (including evidence synthesis)"}
{"mpox_priority_code":"04","mpox_priority":"Clinical characterisation and management","mpox_subpriority_code":"0402","mpox_subpriority":"Spectrum & determinants of mpox clinical presentation, pathogenesis & disease course"}
{"mpox_priority_code":"04","mpox_priority":"Clinical characterisation and management","mpox_subpriority_code":"0403","mpox_subpriority":"Treatment approaches in advanced HIV disease or other immunocompromising conditions."}
{"mpox_priority_code":"04","mpox_priority":"Clinical characterisation and management","mpox_subpriority_code":"0404","mpox_subpriority":"Optimal care protocols for standard patient care and prevention of complications"}
{"mpox_priority_code":"05","mpox_priority":"Infection prevention and control","mpox_subpriority_code":"0501","mpox_subpriority":"Evidence synthesis to support evidence-based decision-making"}
{"mpox_priority_code":"06","mpox_priority":"Therapeutics research, development and implementation","mpox_subpriority_code":"0601","mpox_subpriority":"Development of equitable, accessible, safe & effective therapeutics"}
{"mpox_priority_code":"07","mpox_priority":"Vaccines research, development and implementation","mpox_subpriority_code":"0701","mpox_subpriority":"Development of equitable, accessible, safe and effective vaccines"}
{"mpox_priority_code":"07","mpox_priority":"Vaccines research, development and implementation","mpox_subpriority_code":"0702","mpox_subpriority":"Immunisation strategies to optimise use of available vaccines"}
{"mpox_priority_code":"08","mpox_priority":"Policies for public health, disease control &  community resilience","mpox_subpriority_code":"0801","mpox_subpriority":"Risk communication & community engagement e.g.  key populations"}
{"mpox_priority_code":"08","mpox_priority":"Policies for public health, disease control &  community resilience","mpox_subpriority_code":"0802","mpox_subpriority":"Behavioural drivers of risk and protection in different contexts"}
{"mpox_priority_code":"08","mpox_priority":"Policies for public health, disease control &  community resilience","mpox_subpriority_code":"0803","mpox_subpriority":"Evaluation of elimination strategy implementation in different contexts."}
{"mpox_priority_code":"09","mpox_priority":"Secondary impacts of disease, response & control measures","mpox_subpriority_code":"0901","mpox_subpriority":"Prevention of complications & social sequelae"}
{"mpox_priority_code":"10","mpox_priority":"Health Systems Research","mpox_subpriority_code":"1001","mpox_subpriority":"Optimal provision of clinical care for mpox"}
{"mpox_priority_code":"10","mpox_priority":"Health Systems Research","mpox_subpriority_code":"1002","mpox_subpriority":"Support measures & protection of HCWs/caregivers"}